Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN – Get Free Report) were down 6.2% on Thursday. The company traded as low as $45.62 and last traded at $45.8030. 79,091 shares were traded during trading, a decline of 82% from the average session volume of 432,052 shares. The stock had previously closed at $48.84.
Wall Street Analyst Weigh In
A number of equities analysts have commented on the stock. KeyCorp initiated coverage on shares of Guardian Pharmacy Services in a report on Tuesday, September 22nd. They issued an “overweight” rating and a $52.00 target price for the company. Oppenheimer raised their price target on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a report on Friday, August 7th. Truist Financial raised their price target on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a “buy” rating in a report on Monday, September 21st. Wall Street Zen upgraded shares of Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research note on Saturday, November 14th. Finally, Weiss Ratings upgraded shares of Guardian Pharmacy Services from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, November 9th. Nine equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $45.57.
Read Our Latest Report on Guardian Pharmacy Services
Guardian Pharmacy Services Stock Performance
The firm’s 50 day simple moving average is $43.03 and its 200 day simple moving average is $39.21. The firm has a market capitalization of $2.98 billion, a price-to-earnings ratio of 40.25, a PEG ratio of 2.58 and a beta of 0.06.
Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last issued its earnings results on Thursday, November 5th. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.02. Guardian Pharmacy Services had a net margin of 5.13% and a return on equity of 30.29%. The firm had revenue of $371.07 million during the quarter, compared to analysts’ expectations of $365.76 million. As a group, sell-side analysts forecast that Guardian Pharmacy Services, Inc. will post 1.23 earnings per share for the current year.
Institutional Trading of Guardian Pharmacy Services
Hedge funds have recently modified their holdings of the stock. Nisa Investment Advisors LLC increased its holdings in shares of Guardian Pharmacy Services by 53.5% during the 3rd quarter. Nisa Investment Advisors LLC now owns 1,050 shares of the company’s stock worth $43,000 after buying an additional 366 shares during the last quarter. State of Alaska Department of Revenue raised its position in Guardian Pharmacy Services by 105.9% in the third quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company’s stock valued at $97,000 after purchasing an additional 1,229 shares during the period. Aquatic Capital Management LLC acquired a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at $235,000. Voya Investment Management LLC acquired a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at $238,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Guardian Pharmacy Services during the 2nd quarter worth $335,000.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents’ medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.
Read More
- Five stocks we like better than Guardian Pharmacy Services
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
